Minimizing the Regulatory Ripple Effect for Quality and Training in Drug Safety Organizations
Even a slight change to a regulation can have a huge effect throughout an organization. Given the recent overhaul of the EMA drug safety requirements, the ‘ripple effect’ is more like a tidal wave. In this podcast, Amber Scorah of Pharma IQ, gets some best practices for minimizing ripples from two of Pfizer’s key leaders: Nancy Grey, Director, Quality Standards and Training, Worldwide Safety and Regulatory Operations, and Virginia Klunder, Director, Compliance Analytics, Qual...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.